Bioventus divested its Advanced Rehabilitation business to enhance focus on core operations. Strong performance in Pain Treatments was driven by sales team execution. Surgical Solutions segment saw growth in Ultrasonics and BGS. The company plans to sustain growth through investments in R&D and commercial execution.